Quarterly report pursuant to Section 13 or 15(d)

EARNINGS PER SHARE (Tables)

v3.24.3
EARNINGS PER SHARE (Tables)
 9 Months Ended
Sep. 30, 2024
Earnings Per Share [Abstract]  
SCHEDULE OF ANTI DILUTIVE SECURITIES

The following potentially dilutive securities were excluded from the calculation of diluted net loss per share because the effects were anti-dilutive based on the application of the treasury stock method and because the Company incurred net losses during the period:

 

                         
    For the Nine Months Ended September 30,     For the Three Months Ended September 30,  
    2024     2023     2024     2023  
Convertible notes payable     509,504       546,185       509,504       546,185  
Restricted stock units     41,566       12,885       12,424       4,295  
Warrants to purchase shares of common stock     251,125       53,167       251,125       53,167  
Total potentially dilutive shares     802,195       612,237       773,053       603,647  
SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET INCOME PER SHARE

The following table sets forth the computation of basic and diluted net income per share:

 

                         
    Nine Months Ended September 30,     Three Months Ended September 30,  
    2024     2023     2024     2023  
                         
Net loss attributable to the common stockholders   $ (2,817,394 )   $ (2,969,886 )   $ (1,196,923 )   $ (905,726 )
                                 
Basic weighted average outstanding shares of common stock     1,245,885       1,050,782       1,268,795       1,105,844  
Dilutive effect of options and warrants     -       -       -       -  
Diluted weighted average common stock and common stock equivalents     1,245,885       1,050,782       1,268,795       1,105,844  
                                 
Loss per share:                                
Basic and diluted   $ (2.26 )   $ (2.83 )   $ (0.94 )   $ (0.82 )